Press Releases

Date Title and Summary Additional Formats
Toggle Summary Quotient Limited to Publish Quarterly Investor Presentation
JERSEY, Channel Islands, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Quotient Limited  (NASDAQ:QTNT), a commercial-stage diagnostics company, today published the latest investor presentation associated with the earnings call for fiscal quarter ended June 30, 2020 .
View HTML
Toggle Summary Quotient Limited Reports First Quarter Fiscal 2021 Results and Business Update
Significant progress in three targeted areas of MosaiQ development – COVID-19 antibody test, potential new applications, and transfusion diagnostics Ten commercial placements of MosaiQ platform in Europe and the US Continued YoY Strong Top Line Growth for Alba by Quotient reagents Added to Russell
View HTML
Toggle Summary Quotient Announces Equity Awards
JERSEY, Channel Islands, July 23, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland today announced that Dr. Isabelle Buckle , Ph.D. and Dr. Catherine Larue , Ph.D.
View HTML
Toggle Summary Quotient Announces Appointment of Two New Board Members
JERSEY, Channel Islands, July 23, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland , today announced changes in the composition of its board of directors that will take effect later this year.  Two of
View HTML
Toggle Summary Quotient Limited Reports Impressive Results from an Independent SARS-CoV-2 Antibody Detection Study Conducted in Spain
JERSEY, Channel Islands, July 20, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland , today reported that an independent study conducted in Madrid, Spain has confirmed the high performance
View HTML
Toggle Summary Quotient Limited to Report First Quarter 2021 Financial Results and Host Conference Call
JERSEY, Channel Islands, July 17, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal first quarter ended June 30, 2020 will be released before market open on Monday, August 3, 2020 .
View HTML
Toggle Summary Quotient Limited Added to the Russell 2000 and Russell 3000 Indexes
JERSEY, Channel Islands, July 01, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland , today announced that the Company has been added to the Russell 2000® and 3000® Indexes, effective June
View HTML
Toggle Summary Quotient Limited Provides Update on COVID-19 Antibody Test Progress, Other Key Developments and Fourth Quarter and Full Year Fiscal 2020 Results
Developed a high performance COVID-19 Antibody Test Several customer contracts signed for MosaiQ system and COVID-19 Antibody Test Transfusion Dx Expanded Immunohematology (IH) Field Trials have restarted following COVID related delays Initial Serological Disease Screening (SDS) CE Mark obtained
View HTML
Toggle Summary Quotient Limited to Participate in the Jefferies Virtual Healthcare Conference
JERSEY, Channel Islands, May 26, 2020 (GLOBE NEWSWIRE) -- Quotient Limited  (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the Company will present at the Jefferies Virtual Healthcare Conference on Tuesday, June 2, 2020 at 9:00 a.m. ET.
View HTML
Toggle Summary Quotient Limited to Report Fiscal Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call
JERSEY, Channel Islands , May 26, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal fourth quarter and full year ended March 31, 2020 will be released before market open on Tuesday, June 9, 2020 .
View HTML